# Duvelisib: First Global Approval

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/duvelisib-first-global-approval/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hannah A. Blair |
| Citations | 131 |
| DOI | 10.1007/s40265-018-1013-4 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2901488820 |
| PMID | 30430368 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Hannah A. Blair](https://scholariq.org/researchers/hannah-a-blair/)

## Paper journal

- [Drugs](https://scholariq.org/journals/drugs/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.